Axsome Therapeutics AXSM Finance Lease Liability, Current
Finance Lease Liability, Current at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's finance lease liability, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's finance lease liability, current?
- Axsome Therapeutics (AXSM) reported finance lease liability, current of $3.19M in Q1 2026.
- How has Axsome Therapeutics's finance lease liability, current changed year-over-year?
- Axsome Therapeutics's finance lease liability, current increased by 75.8% year-over-year, from $1.82M to $3.19M.
- What does finance lease liability, current mean?
- The amount of lease payments due within one year.
- How do you interpret finance lease liability, current?
- An increase indicates higher short-term cash commitments for leased assets.
- How does finance lease liability, current compare across companies?
- Standardized across companies reporting under current lease accounting standards.